These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 3238937
1. [Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography]. Kovalishin IaF, Nikolaev VG, Baran EIa, Dudar' IA, Iushko LA. Vopr Med Khim; 1988; 34(6):23-6. PubMed ID: 3238937 [Abstract] [Full Text] [Related]
3. Analytical study for separation of middle molecules. Saito A, Kanazawa I, Chung TG, Maeda K. Artif Organs; 1981; 4 Suppl():13-6. PubMed ID: 6975092 [Abstract] [Full Text] [Related]
5. Technical aspects on middle molecules: separation, isolation, and identification. Cueille G, Man NK, Sausse A, Farges JP, Funck-Brentano JL. Artif Organs; 1981; 4 Suppl():8-12. PubMed ID: 7295100 [Abstract] [Full Text] [Related]
6. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients. Popławski A, Myśliwiec M. Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345 [No Abstract] [Full Text] [Related]
7. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]]. Popławski A, Myśliwiec M, Soszka J. Pol Tyg Lek; 1993; 45(40-41):810-3. PubMed ID: 2096374 [Abstract] [Full Text] [Related]
8. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate. Ringoir SM, van Landschoot N, de Smet R. Clin Nephrol; 1980 Mar; 13(3):109-12. PubMed ID: 7379359 [Abstract] [Full Text] [Related]
9. Low molecule and middle molecule metabolites with haemodynamic activity in the ultrafiltrate from uraemic patients (author's transl). Pogglitsch H, Petek W, Waller J, Stübchen-Kirchner H. Wien Klin Wochenschr; 1977 Dec 23; 89(24):812-9. PubMed ID: 595605 [Abstract] [Full Text] [Related]
10. Characterization of middle molecule compounds. Zimmerman L, Jörnvall H, Bergström J, Fürst P, Sjövall J. Artif Organs; 1981 Dec 23; 4 Suppl():33-6. PubMed ID: 7295092 [Abstract] [Full Text] [Related]
14. Amino acid composition of uremic middle and low molecular weight retention products. Bazilinski N, Shaykh M, Ahmed S, Musiala T, Williams RH, Poulos A, Dubin A, Dunea G. Adv Exp Med Biol; 1987 Dec 23; 223():197-204. PubMed ID: 3447436 [Abstract] [Full Text] [Related]
15. Uremic middle molecules in non-dialyzed azotemic patients: relation to symptoms and clinical biochemistries. Asaba H, Alvestrand A, Bergström J, Fürst P, Yahiel V. Clin Nephrol; 1982 Feb 23; 17(2):90-5. PubMed ID: 7067171 [Abstract] [Full Text] [Related]
16. Methodology for identification of serum middle molecules. Buzio C, Montagna G, Calderini C, Manari A, Migone L. Artif Organs; 1981 Feb 23; 4 Suppl():22-7. PubMed ID: 7295090 [Abstract] [Full Text] [Related]
17. Separation, identification of uremic middle molecules, and preliminary study on their toxicity. Li G, Chu J, Liu X, Yuan Z. Clin Chim Acta; 2004 Dec 23; 350(1-2):89-98. PubMed ID: 15530464 [Abstract] [Full Text] [Related]
18. Separation, isolation and amino acid composition of uremic peptides. Shaykh M, Dubin A, Dunea G, Mamdani B, Ahmed S. Clin Physiol Biochem; 1984 Dec 23; 2(1):1-13. PubMed ID: 6488692 [Abstract] [Full Text] [Related]
19. Serum middle molecules in uremia. Buzio C, Manari A, Calderini C, Montagna G, Migone L. Artif Organs; 1981 Dec 23; 4 Suppl():143-50. PubMed ID: 7295081 [No Abstract] [Full Text] [Related]
20. [Detection of uremic peaks by high performance liquid chromatography and their behavior]. Koide K, Toyama J, Inoue N, Koshikawa S, Akizawa T, Takahashi K, Hidaka S, Yamane Y, Nakao M, Uehara Y. Nihon Jinzo Gakkai Shi; 1986 Aug 23; 28(8):1101-10. PubMed ID: 3807043 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]